Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirin

By Kreutz Rolf P.   Nystrom Perry   Kreutz Yvonne   Miao Jia   Kovacs Richard   Desta Zeruesenay   Flockhart David A.   Jin Yan  

Platelets, Vol. 24, Iss. 2, 2013-03 ,pp. : 145-150

Informa Healthcare

Access to resources Recommend Favorite

Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100

By Madsen Esben   Schmidt Erik   Maurer-Spurej Elisabeth   Kristensen Søren  

Platelets, Vol. 19, Iss. 5, 2008-08 ,pp. : 335-341

Informa Healthcare

Access to resources Recommend Favorite

To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatment

By van der Stelt Cornelia   van Werkum Jochem   Seesing Toine   Berg Jurriën M. Ten   Hackeng Christian  

Platelets, Vol. 18, Iss. 7, 2007-11 ,pp. : 550-553

Informa Healthcare

Access to resources Recommend Favorite

Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects

By Payne Christopher   Li Ying   Brandt John   Jakubowski Joseph   Small David   Farid Nagy   Salazar Daniel   Winters Kenneth  

Platelets, Vol. 19, Iss. 4, 2008-06 ,pp. : 275-281

Informa Healthcare

Access to resources Recommend Favorite

Effect of combined administration of clopidogrel and lysine acetylsalicylate versus clopidogrel and aspirin on platelet aggregation and activated GPIIb/IIIa expression in healthy volunteers

By Majluf-Cruz Abraham   Chavez-Ochoa Adriana Ruiz de   Majluf-Cruz Karim   Coria-Ramirez Erika   Pineda Del Aguila Ignacio   Treviño-Perez Sandra   Matías-Aguilar Lisneth   López-Armenta Julio César   Corona de la Peña Norma  

Platelets, Vol. 17, Iss. 2, 2006-03 ,pp. : 105-107

Informa Healthcare

Access to resources Recommend Favorite